We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other safe stocks to buy for the long term in 2025.
The US stock market is often regarded as one of the most reliable and resilient financial markets in the world. With its deep liquidity, broad participation, and historical ability to recover from downturns, it has long been a cornerstone of wealth creation for individual and institutional investors. While it is subject to short-term volatility, its long-term performance and structural advantages make it a reliable platform for investment. It has a proven track record of delivering strong returns over the long term. The S&P 500, a benchmark index that represents the performance of 500 large-cap US companies, has averaged an annual return of approximately 10% since its inception in 1926. While short-term fluctuations are inevitable, the market’s historical trajectory has been one of growth, driven by corporate innovation, economic expansion, and rising consumer demand.
Read more about these developments by accessing 10 Best AI Data Center Stocks and 10 Buzzing AI Stocks According to Goldman Sachs.
During major crises such as the Great Depression, the 2008 financial crisis, and the COVID-19 pandemic, the market experienced sharp declines but eventually rebounded to new highs. For example, after the COVID-19 crash in March 2020, the S&P 500 recovered within six months and went on to hit record levels, underscoring its resilience. One of the key factors contributing to the reliability of the US stock market is its breadth and diversity. The market includes a wide array of industries, from technology and health care to consumer goods and energy, allowing investors to diversify their portfolios to reduce risk. Additionally, US exchanges like the New York Stock Exchange and Nasdaq are among the most liquid in the world, making it easy for investors to buy and sell shares efficiently. This liquidity and diversification provide a level of stability that is unmatched in many other markets, offering investors confidence in the market’s ability to withstand shocks and recover from volatility.
Read more about these developments by accessing 30 Most Important AI Stocks According to BlackRock and Beyond the Tech Giants: 35 Non-Tech AI Opportunities.
For this article, we selected stocks that have solid businesses with recurring revenue streams, reliable dividend payouts, and burgeoning growth pipelines. These stocks are also popular among hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
A medical technician wearing protective gloves and a mask mixing a biopharmaceutical solution.
Pfizer Inc. (NYSE:PFE)
Number of Hedge Fund Holders: 80
Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. This company stands as a top investment choice for a variety of reasons. To begin with, the report for the third quarter shows a compelling investment opportunity. The company reported revenues of $17.7 billion, representing 32% year-over-year operational growth. Also, revenues were $13.6 billion, excluding the company’s COVID-19 products, which reflects an operational increase of 14% compared with the prior-year quarter. This underscores the company’s strong financial growth driven by a combination of contributions from Pfizer’s Oncology products, key in-line products, recent commercial launches, and heightened demand for its COVID-19 oral treatment. Secondly, the company has collaborated with The City University of New York (CUNY) Institute for Implementation Science in Population Health (ISPH), which has initiated a critical two-year prospective epidemiologic study to track acute respiratory infections across the United States.
Overall, PFE ranks 8th on our list of safe stocks to buy for the long term in 2025. While we acknowledge the potential of PFE as an investment, our conviction lies in the belief that some stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for a stock that is more promising than PFE but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap
Disclosure: None. This article is originally published at Insider Monkey.
